High-Altitude Pulmonary Edema
- 7 March 1996
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 334 (10) , 662-664
- https://doi.org/10.1056/nejm199603073341013
Abstract
High-altitude pulmonary edema occurs in mountaineers who ascend rapidly to heights of more than 2500 m. It is at the severe end of the spectrum of symptoms of acute mountain sickness, which include headache, insomnia, anorexia, lethargy, vomiting, oliguria, and peripheral edema. Vigorous young men are most susceptible to high-altitude pulmonary edema. Other risk factors include strenuous exercise, cold weather, and recent respiratory tract infection. Those who have had high-altitude pulmonary edema in the past are likely to have it again. The symptoms and signs are cough, tachypnea, tachycardia, orthopnea, cyanosis, rales, and frothy pink sputum. Symptoms usually begin two . . .Keywords
This publication has 12 references indexed in Scilit:
- Inhaled Nitric Oxide for High-Altitude Pulmonary EdemaNew England Journal of Medicine, 1996
- Inhaled Nitric Oxide Selectively Reverses Human Hypoxic Pulmonary Vasoconstriction without Causing Systemic VasodilationAnesthesiology, 1993
- Prevention and Treatment of High Altitude Pulmonary Edema by a Calcium Channel BlockerInternational Journal of Sports Medicine, 1992
- Acute pulmonary edema after Blalock-Taussig anastomosisThe Annals of Thoracic Surgery, 1992
- Prevention of High-Altitude Pulmonary Edema by NifedipineNew England Journal of Medicine, 1991
- High-altitude pulmonary edema. Characteristics of lung lavage fluidJAMA, 1986
- Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema.Circulation, 1985
- Abnormal Circulatory Responses to High Altitude in Subjects with a Previous History of High-Altitude Pulmonary EdemaCirculation, 1971
- Transarterial Leakage: A Possible Mechanism of High Altitude Pulmonary OedemaPublished by Wiley ,1971
- Unilateral chronic pulmonary edema and pleural effusion after systemic-pulmonary artery shunts for cyanotic congenital heart disease∗The American Journal of Cardiology, 1967